RLG
0.004
100%
ARO
0.002
-33.3%
H2G
0.011
37.5%
NAE
0.002
-33.3%
CPN
0.14
33.3%
CAY
0.06
-31%
WRX
0.024
26.3%
LAM
0.53
-29.8%
OVT
0.005
25%
LKO
0.35
-25.5%
RGL
0.01
25%
CAN
0.003
-25%
SOP
0.048
20%
CMO
0.006
-25%
AT4
0.049
19.5%
PER
0.003
-25%
CRN
0.195
18.2%
VRL
0.01
-23.1%
EVG
0.026
18.2%
ACM
0.026
-21.2%
MML
0.013
18.2%
GTE
0.008
-20%
APX
1.02
17.9%
OSX
0.004
-20%
AAU
0.007
16.7%
G50
0.53
-19.7%
H3E
0.007
16.7%
AGD
0.105
-19.2%
PGD
0.185
15.6%
DVP
4.6
-17.6%
USC
0.023
15%
FAU
0.005
-16.7%
CYC
0.595
14.4%
NFM
0.005
-16.7%
PXX
0.016
14.3%
OMG
0.005
-16.7%
VFY
3.5
13.3%
VHL
0.01
-16.7%
BIO
0.3
13.2%
C29
0.011
-15.4%
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

CYC Signed first U.S. contract with Duke University

Cyclopharm (ASX:CYC) announces the first signed U.S. contract for Technegas with Duke University Hospital following approval of by the USFDA on 29 September 2023 | ASX Announcement: https://announcements.asx.com.au/asxpdf/20231205/pdf/05y66m6jl37slv.pdf #CYC #USA #Technegas #shorts